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Summary
Background Addressing the growing burden of men-
tal diseases is a public health priority. Nevertheless,
many countries lack reliable estimates of the propor-
tion of the population affected, which are crucial for
health and social policy planning. This study aimed to
collect existing evidence on the prevalence of mental
diseases in Austria.
Methods A systematic review was conducted using
MeSH, EMTREE and free-text terms in seven biblio-
graphic databases. In addition, the references of in-
cluded papers and relevant Austria-specific websites
were searched. Articles published after 1996 pertain-
ing to the Austrian adult population and presenting
prevalence data for mental diseases were included in
the analysis.
Results A total of 2612 records were identified in the
database search, 19 of which were included in the
analysis, 13 were community-based studies and 6 ex-
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amined institutionalized populations. Sample sizes
ranged from 200 to 15,474. The evidence was cen-
tered around depression (n=6, 32%), eating disor-
ders (n= 4, 21%) and alcohol dependence (n=3, 16%).
While most studies (n= 10, 53%) used questionnaires
and scales to identify mental diseases, seven studies
used structured clinical interviews, and two studies
examined use of psychotropic drugs. Due to the diver-
sity of methodologies, no statistical pooling of preva-
lence estimates was possible.
Conclusion Information on the prevalence of mental
diseases in Austria is limited and comparability be-
tween studies is restricted. A variety of diagnostic in-
struments, targeted populations and investigated dis-
eases contribute to discrepancies in the prevalence
rates. A systematic, large-scale study on the preva-
lence of mental diseases in Austria is needed for com-
prehensive and robust epidemiological evidence.
Keywords Mental disorders · Austria · Prevalence ·
Systematic review · Survey methods
Introduction
Mental diseases are associated with high economic
and societal burden and reduction in the quality of
life of those affected [1, 2]. According to the Global
Burden of Disease Study 2010, the burden of men-
tal diseases has increased by 38% worldwide between
1990 and 2010 and is continuously growing [3]. On av-
erage around 38% of the population of the European
Union are affected each year by mental health prob-
lems [4]. Among the European countries, the lifetime
prevalence was estimated at 41% and 43%, whereas
12-month prevalence was 23% and 31% in the Nether-
lands and Germany, respectively [5, 6]. Evidence from
a more recent study, the European Study of the Epi-
demiology of Mental Disorders (ESEMeD), showed
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that nearly 1 in 10 respondents reported the presence
of affective disorders, anxiety disorders and/or alcohol
abuse (not including other somatoform disorders or
substance abuse) in the past 12 months [7]. A recent
meta-analysis showed that the mortality rate among
people suffering from mental diseases is more than
two times higher compared to the general population
or people without mental diseases [8].
An accurate account of the proportion of the popu-
lation affected bymental diseases in many countries is
still lacking [9] hindering opportunities for detection
of unmet needs, prevention and early interventions.
International differences in populations and health-
care systems also highlight the importance of country-
specific epidemiological studies [10]. Comparisons
between existing evidence, however, are impeded by
the heterogeneity of choice of concepts and methods
used to estimate the prevalence rates of mental dis-
eases [1, 11–13]. These are mostly related to the use
of different case-finding tools, i. e. the instruments
utilized for identifying psychiatric cases [6, 14]. Com-
mon methods of case-finding include the use of either
structured clinical interviews, e.g. Schedules for Clin-
ical Assessment in Neuropsychiatry (SCAN), which
allow classification of diseases to categories of the
Diagnostic and Statistical Manual of Mental Disorders
(DSM) and International Classification of Diseases
(ICD) [15], or screening instruments, mostly ques-
tionnaires and symptom rating scales that are able
to assess psychological symptoms of diseases rather
than clinical diagnoses [16]. Both methods have been
used across epidemiological studies [13]; however, it
has been shown that screening instruments include
numerous false positive results and therefore report
generally higher prevalence estimates in comparison
to the studies that used DSM or ICD diagnostic crite-
ria [13]. Structured clinical interviews are more able to
separate symptoms among specific mental diseases or
from those linked to physical illnesses [17]. They are,
however, very resource intensive as they require a clin-
ician or researcher trained in psychiatry/psychology
to conduct interviews [18], whereas symptom scales
are mostly self-reported questionnaires completed by
a study participant with or without the assistance of
a researcher.
Austria, similarly to other high-income countries,
has been experiencing changes in the provision of
mental health services since the 1970s [19]. These
changes were based on the idea of reorganizing pro-
vision of mental health care from large, centralized
institutions to decentralized community-based care
[20]. While the number of mental health hospital beds
was reduced by 62% between 1970 and 2002 [21], the
length of stay for mental diseases shortened from 38.3
to 16 days between 1990 and 2000 (58%) and has re-
mained on the same level since (15.9 days in 2014)
[22].
Although the structural changes in mental health
care are still ongoing, these are not based on rele-
vant evidence for needs. With no access to uniform
epidemiological data, such as specialist registries,
comprehensive estimates on the population mental
health are currently only available from administra-
tive data from the 19 healthcare funds in Austria.
According to these, around 900,000 people (approxi-
mately 10% of the general population [23]) received
mental health care in 2009 [24]. The frequency of
mental health conditions as causes for disability pen-
sions have tripled (10.8% in 1995, 35.6% in 2015) [25,
26]. In 2015, 2.3% of sick leave cases, 9.2% of all sick
days, and the second highest average length of a sick
leave at 38 days were attributed to mental diseases
[27]; however, these estimates are likely to be great
underestimations due to the substantial degree of
unmet needs for treatment, the misdiagnoses, stigma
and coding bias similarly to other EU countries [1].
For example, Alonso et al. (2004) found that approx-
imately two thirds (63%) of people suffering from
depression did not receive any treatment in the last
12 months [28].
Robust epidemiological estimates on the occur-
rence of a disease are central to adequate health care
planning, and prevention and promotion activities.
Systematic reviews are important tools to provide this
information in an integrated form [29]. In Austria,
information available in the peer-reviewed literature
on the epidemiology of mental disorders has not yet
been collated and presented in a systematic and ag-
gregated form. The first objective of this study was
to collect and synthesise available information on
the prevalence of mental diseases among the adult
Austrian population. The second objective was to
describe the comparability of the different applied
methods, including case-finding.
Methods
Database search
A systematic literature review was carried out to col-
lect all evidence on the epidemiology, i. e. prevalence,
incidence and mortality, of mental diseases among
the adult population in Austria published between
January 1996 and May 2016. Searches were con-
ducted in seven bibliographic databases: MEDLINE,
EMBASE, Scopus, PsycINFO, CINAHL, Social Science
Citation Index (SSCI) and PSYNDEXplus. The liter-
ature search used a combination of MeSH, EMTREE
and free-text terms (Supplementary material Table 1).
Furthermore, searches for relevant literature included
inspecting the reference lists of included articles and
searching national websites (i. e. Statistik Austria, LBI
HTA, Gesundheit Österreich GmbH, Hauptverband
der österreichischen Sozialversicherungsträger and
HIS) using German search terms. The searches were
performed in May 2016.
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Screening and eligibility
First, screening of titles and abstracts was performed
to exclude non-relevant articles. Full-text screening
of potentially relevant papers was then carried out.
The following exclusion criteria were applied: (1) it
was not possible to extract epidemiological data for
the Austrian adult population, (2) studies and reports
referring only to statistics on hospital admissions and
discharge rates, (3) duplicate articles or multiple pub-
lications of the same study population, (4) only ab-
stracts or conference papers, and (5) studies published
before 1996. Initially no language filter was applied
but ultimately, studies in English and German were
included.
Mental disorders of interest included: psychotic
disorders (schizophrenia, schizoaffective disorders),
mood disorders (depression, bipolar disorder, dys-
thymia), anxiety disorders, stress-related disorders,
eating disorders and substance use disorders. Neu-
rodevelopmental disorders (e.g. intellectual disabil-
ities, autism, attention-deficit disorders), neurocog-
nitive disorders (e.g. dementia) as well as mental
diseases described as comorbidities of other health
problems were not considered. If multiple publica-
tions for the same study population presenting the
same epidemiological data were found, the most in-
formative (i. e. allowing extraction of more data for
the analysis) article was considered.
In this review, the term “epidemiology” is defined
as any data on prevalence, incidence or mortality re-
lated tomental diseases. “Prevalence” is defined as the
proportion of population that suffers from a defined
condition at a defined point or period of time, e.g.
12-month prevalence, lifetime prevalence and “inci-
dence” as the number of new occurrences of a health
problem in a defined period of time [30].
Study quality
The quality of the studies was assessed using the cri-
teria for critical appraisal of prevalence and incidence
studies developed by Loney et al. (1998) [31]. This
consists of a scoring system that rates eight quality
criteria. A score of 1 or 0 is assigned to each item
making 8 the maximum score that could be obtained
[31]. No cut-off point was suggested by the authors.
Analysis
Similar to other relevant international reviews [32, 33],
this article includes studies based both on general
and institutionalized populations (i. e. nursing homes,
hospitals, prisons). Findings are summarized and pre-
sented separately. Due to the diversity of method-
ologies, settings and study outcomes among the in-
cluded publications, no statistical pooling was possi-
ble. Therefore, main findings were synthesized narra-
tively.
Results
A total of 2612 records were identified in the databases
search and 15 reports through the website search.
First and second-level screening resulted in a total
of 19 peer-reviewed articles on the epidemiology of
mental diseases in Austria which were included in
the analysis. None of the reports from the website
search were suitable for inclusion as no epidemiolog-
ical data meeting the inclusion criteria were available.
A flow diagram of the literature search based on the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) [34] is presented in Fig. 1.
A detailed description of the included articles is pre-
sented in Supplementary Material Table 2.
More than a half of the articles were community-
based studies with randomly selected samples (n= 12)
[35–46] and one examined a sample of 18-year-old
men assessed for a mandatory military service in one
Austrian state [47]. Out of the remaining six studies,
three were conducted among patients of general hos-
pital wards [48–50], three among nursing home resi-
dents [50–52] (one study included both nursing homes
and hospitals [50]), and one examined a sample of
prison inmates of one prison located in Vienna, Jus-
tizanstalt Wien-Josefstadt [53]. Sample sizes ranged
from 200 to 15,474 individuals. The year of identified
prevalence estimates varied from 1991 to 2011. The
majority of studies were national studies (n=15) and
four articles pertained to international studies where
two or more counties were participating [35, 39, 44,
50]. Different methods of acquiring data were used.
Out of the 12 studies that were based on randomly
selected samples, three used data from existing inter-
national surveys (European Health Interview Survey,
European Social Survey Round 3 and Survey of Health,
Ageing and Retirement in Europe) [35, 39, 44]. The re-
maining nine used their own samplingmethods which
included using telephone directories [36, 42, 43], cen-
sus bureau data [37, 38, 40, 54] and district voting reg-
istries [41, 45]. Of the studies six selected study par-
ticipants from the population residing in institutions
[48–53] and one study assessed a sample of 18-year-
old men assessed for a mandatory military service in
one Austrian state [47]. Out of all articles included
(n= 19), diagnostic interviews were applied in six stud-
ies [41, 45, 48, 49, 52, 53]. Otherwise, evidence was
collected using self-completed questionnaires (n=7)
[35, 39, 40, 43, 44, 46, 47], telephone surveys (n=4)
[36–38, 42], or obtained from patient medical records
[51]. In one study both diagnostic interviews and self-
completed questionnaires were used [50].
Most studies presented results for point (current)
prevalence of mental diseases (n= 15) [35, 37–40, 43,
45, 47–54], others reported 10-year [42], 2-week [36]
and 1-week [44] prevalence rates. One study reported
incidence [41].
The quality scores of the studies ranged from 3 to 6
with a mean of 4.79 (SD 1.03), using criteria adopted
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Fig. 1 Flow diagram of the systematic literature search. *Endnote X7 was used for reference management
from Loney et al. (1998) [31]. Of the studies 10 used
trained interviewers to minimize a possible measure-
ment bias [35, 37–39, 41, 45, 48, 49, 51, 52]. Study sub-
jects were randomly selected from the general popu-
lation in 10 studies thus minimizing the potential for
selection bias [35–40, 42–44, 46]. A summary of preva-
lence estimates found in the review is presented in
Supplementary material Table 3 for the general pop-
ulation and Table 4 for institutionalized populations.
A short summary of the main findings is provided.
Mental diseases in the general population
A total of 13 community-based studies were included.
None of the studies examined the overall prevalence
of all psychiatric disorders within the general Austrian
population. The primary outcome was to identify the
prevalence of depressive disorders (n=6) [35, 36, 41,
42, 44, 55], followed by eating disorders (n= 4) [37, 38,
40, 46], two studies examined the prevalence of alco-
hol dependence [43, 47] and one study looked at in-
dividuals who received psychopharmacological treat-
ment [39].
Depression, seasonal depressive disorder and anxiety
Of the studies six examined the prevalence rates of
depression in the general population [35, 36, 41, 42,
44, 45]. The sample size varied from 331 to 3448 and
the prevalence estimates ranged from 9.9% (2-week
prevalence) to 15.6% (10-year prevalence) for the adult
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population and from 16% to 19.6% (point prevalence)
for older adults.
The 10-year prevalence of seasonal depressive dis-
order (SAD) was 2.5% and 1.8% applying DSM-V and
ICD-10 criteria, respectively [42]. In addition, one
study found the incidence of new cases of depression
in the respondents aged 75 years and above with no
history of depression at 16.6% over 30-month follow-
up [41].
Eating disorders
A total of four studies examined the epidemiology of
eating disorders in the Austrian population [37, 38, 40,
46] with sample sizes varying between and 475 and
1000 respondents. Among women aged 40–60 years,
point prevalence of eating disorders defined as occur-
rence of anorexia nervosa, bulimia nervosa or eating
disorders not otherwise specified (EDNOS) was esti-
mated at 4.6%. In addition, 4.8% of women met the
criteria for subthreshold eating disorders [46]. Slightly
lower point prevalence rates were observed in women
within the age group 60–70 years; 3.8% had eating
disorders and 4.4% had single symptoms of eating
disorders [40]. In another sample of women aged
18–85 years, 3.3% were diagnosed with binge eating
disorder (BED) and 1.5% suffered from bulimia ner-
vosa [38]. Among men, the point prevalence of BED,
partial BED and EDNOS was found to be 0.8%, 4.20%,
and 0.50%, respectively. The total prevalence of clin-
ical and subclinical eating disorders was surprisingly
high for men (14.9%) [37]; however, it is difficult to
interpret this high rate as the authors did not provide
a definition of subclinical eating disorders.
Alcohol and substance dependence
Rathner et al. (1998) examined the prevalence of alco-
hol dependence across the Austrian population. The
study was conducted in 1996 and showed that 2.2%
of the studied population at the time of the study
were alcohol dependent [43]. In another study, among
all 18-year-old males undergoing assessment for Na-
tional Military Service in Lower Austria, 3.2% were
identified as having alcohol dependence, whereas 15%
had issues with alcohol abuse [47].
Psychotropic treatment
Kopp et al. (2011) reported based on the Austrian
Health Interview Survey (2006/2007) that out of 15,474
interviewed adults, 5.7% had received psychopharma-
cological treatment in the last 12 months for depres-
sion, anxiety or both [39].
Mental diseases in the institutionalized population
A total of six articles examined mental diseases in in-
stitutionalized populations. Of these, three articles re-
ferred to nursing home residents [50–52], three were
concerned with patients of general (non-psychiatric)
hospital wards [48–50] (one study included both nur-
ing homes and hospitals [50]) and one was conducted
in a prison [53].
Nursing homes
At least one psychiatric or neurological disorder was
diagnosed in 76% of the 262 newly admitted nursing
home residents in Tyrol and Vienna in 1991–1992 [52].
The most common diagnoses fell into the categories
dementia or other organic illnesses (64.9%), adjust-
ment, neurotic or psychosomatic disorders (16.8%),
substance abuse disorders (4.2%), depressive disor-
ders (3.4%), manic depressive or other psychoses
(2.3%) and schizophrenia (1.9%) [52]. Another study
showed that roughly 75% of the residents of nursing
homes in the Austrian state of Vorarlberg received
psychotropic medication at least once in the preced-
ing year (36.8% of them received antidepressants)
[51].
Assessed with the Structured Clinical Interview for
DSM-IV (SCID), alcohol dependence was diagnosed
in 0.7% of nursing home residents in a combined
sample of 33 nursing homes from the Austrian state
of Salzburg. Problematic alcohol consumption was
identified in 5.7% and 5.5% of study participants us-
ing the Alcohol Use Disorder Identification Test (AU-
DIT) and the Short Michigan Alcoholism Screening
Test (SMAST-G), respectively [50]. In addition, 2.6%
of the nursing home residents were diagnosed with
abuse of or addiction to medication [50].
General hospital wards
Approximately one third (32.2%) of the 821 patients
of general (non-psychiatric) hospital wards were di-
agnosed with mental diseases [48]. Dementia was the
most frequent (11.6%), followed by depression (10%)
and substance abuse disorders (5.8%) [48]. A similar
study estimated the prevalence of psychiatric disor-
ders at 30% among 784 patients of the general hospital
wards [49].
Prisons
Of the studies one examined the prevalence of psy-
chiatric disorders among both convicted and remand
prisoners in one prison located in Vienna [53]. A high
proportion of the studied sample was diagnosed with
one ormoremental disorders (72% convicted and 69%
remanded in custody prisoners). Particularly, sub-
stance dependence and substance use were common
among prisoners as over half of the prisoners (54%
and 57% for convicted and remanded in custody pris-
oners, respectively) regularly consumed one or more
substances. Mood disorders were found in 4% of the
convicted prisoners and 13% of the remand prisoners.
Schizophrenia was diagnosed in 3% of both groups
[53].
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Differences according to gender and
socioeconomic status
Only six studies mentioned statistically tested dif-
ferences in the prevalence rates between men and
women, three studies reported that there was no sta-
tistically significant difference in the occurrence of
major depression or SAD [42], or depression [36] and
mental diseases in general [49]. In a fourth study,
the occurrence of anxiety disorder was found to be
significantly higher for women [36] and two further
studies reported that men suffer more often from al-
cohol dependence [43, 50]. In terms of socioeconomic
status, women with a lower education level and non-
European origin were more likely to suffer from eat-
ing disorders [46]. Moreover, migrant women from
Eastern Europe had significantly higher prevalence
estimates both for depression and anxiety compared
to women with an Austrian origin [36].
Study respondents who received psychopharmaco-
logical treatment were more likely to be older, female,
living alone and have lower income [39]. Meanwhile,
being single and female were both associated with
significantly higher benzodiazepine use among older
people (75+ years) [55].
Discussion
The aims of this literature review were to collate, sum-
marize and compare existing published evidence on
the prevalence of mental diseases in Austria and to
highlight information gaps.
Summary of the main findings and international
comparison
Based on the findings of this review we can conclude
that between 9% (point prevalence) and 15% (10-year
prevalence) of the adult population in Austria may be
affected by depression, 6.5% by anxiety disorders, and
2.5% by SAD. Slightly higher prevalence rates for de-
pressive disorders have been observed in older adults
(50+ years) and older persons (75+ years, 19.6% and
16.3%, respectively). The prevalence of eating disor-
ders was surprisingly high in the Austrian population.
Nearly 5% of women aged ≥40 years had symptoms of
eating disorders. Around 2% of the general population
and 3.2% of 18-year-old male Austrians had problems
with alcohol dependence. Nearly 6% of the individuals
in a household survey reported receiving psychophar-
macological treatment. Over 30% of patients of non-
psychiatric hospital wards were suffering from mental
health conditions and more than 70% of institution-
alized individuals (nursing homes and prisons) were
diagnosed with a mental disease.
Comparisons between the evidence from Austria
and international literature should consider the va-
riety of diagnostic methods applied as well as vari-
ations between the studied groups [11]. Character-
istics of the study samples in terms of different age
groups as well as different definitions of mental dis-
eases adopted may lead to varying results [6, 14].
The point prevalence rates of major depression in
Europe reported by Wittchen et al. were reported at
6.9% in 2011 [4] and 8.3% in 2005 [1] and were lower
than the estimates reported for Austria (9% [36]). In
comparison to the global evidence, the point preva-
lence of major depression was also higher in Austria
(9% vs. 4.7%) [13]. The average lifetime prevalence es-
timates of major depression in 10 high-income coun-
tries (14.6%) reported by Bromet et al. (2011) [56] was
close to the 10-year prevalence reported by Pjrek et al.
(2016) for Austria (15.60%) [42].
The estimate for major depression (MD) in the el-
derly population in Austria (point prevalence of 7.2%
for population 75+ years [45]) was also higher com-
paring to that reported by Volkert et al. (2013), who
found the prevalence of MD in older people in Europe
and North America at 3.29% for current and 16.52%
for lifetime MD [57].
Surprisingly, only six studies reported differences
in the prevalence rates between men and women of
which three studies reported that there were no sta-
tistically significant differences in the prevalence rates
of depression [36, 42], SAD [42] and mental diseases
in general [49]. This is in contrast to international
published evidence showing that women have about
twice as high risk of suffering from depression [13, 56]
or non-seasonal depression [58] than men.
No studies on mortality and only one study on in-
cidence was found in the review. This is not surpris-
ing as incidence estimates require clinical studies with
long periods of follow-up and such studies are there-
fore more costly to conduct and more prone to loss to
follow-up than prevalence studies. Estimating men-
tal diseases-related mortality has additional method-
ological difficulties due to frequent comorbidities. Ac-
cording to the international literature, lower socioeco-
nomic status is associated with poorer mental health
[59] and higher costs of healthcare services [60, 61].
Future policies should also consider looking at the
value of different treatment options in the light of im-
portant and potentially amenable socioeconomic fac-
tors associated with mental diseases. To be able to in-
dicate key areas for healthcare service planning, these
economic factors should be researched along with the
epidemiological data. This review could identify only
marginal evidence on these associations.
Comparability of the applied methods
Different approaches to case-finding were utilized
in the various study samples. Even among the rela-
tively small number of studies included in this review,
a variety of different case-finding instruments was
observed. For example, among six studies present-
ing data on depression, seven different instruments
were used and four different measures were used
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to assess alcohol dependence in the three relevant
identified studies. These results highlight the lack of
standardized methods.
In general, five studies derived prevalence esti-
mates based on cut-off values on a self-reported
questionnaire index which may have led to misinter-
pretation. Respondents who scored high on a self-
reported scale had symptoms of mental diseases but
were not classified as exhibiting a clinical condition.
This limitation of screening questionnaires was men-
tioned by multiple authors using the Centre for Epi-
demiologic Studies Depression (CES-D) scale [35, 44].
On the other hand, some screening questionnaires
may result in considerable amount of false positive
cases and overestimate the prevalence rates [16, 62].
This aspect has been well demonstrated in one study
examining alcohol dependence among nursing home
residents. While the occurrence of alcohol depen-
dence was 0.7% using a structured clinical interview,
the prevalence rates measured by screening instru-
ments were higher, 5.7% and 5.5% using AUDIT and
SMAST-G, respectively [50].
The use of different cut-off values on some symp-
tom scales may cause other problems with compa-
rability between studies. For instance, Kapusta et al.
(2006) used a cut-off value of ≥2 on the CAGE alcohol
screening questionnaire to diagnose alcohol depen-
dence [47], whereas Rathner and Dunkel (1998) used
a cut-off value of 4 [43]. If the approach of ≥2 points
on the CAGE scale would be adopted in Rathner and
Dunkel (1998), 21% of the respondents would fall
into a category of alcohol dependence, compared to
the 3.2% reported (for 18-year-old men) by Kapusta
et al. (2006). The circumstances of collecting data, i. e.
mailed questionnaire vs. completing a questionnaire
during the examination for mandatory military ser-
vice, could also contribute to differing results. While
Bongers and Van Oers (1998) did not observe differ-
ences in self-reported alcohol use assessed by mail
survey and personal interviews [63], more recently
Dotinga et al. (2005) reported that higher alcohol
use in a mailed survey in comparison to face-to-face
interviews [64]. Mangweth-Matzek et al. [46] and Von
Dem Knesebeck et al. [44] also used two different cut-
off values on the CES-D scale in their studies to assess
depressive symptomatology among the studied sam-
ples. Even though the studies were concerned with
the same mental health problem, a direct comparison
of prevalence rates was, therefore, not possible.
Another important factor hindering comparisons
between studies is the type of the prevalence estimate
reported, e.g. point prevalence, lifetime prevalence.
While the 10-year prevalence of depression was re-
ported at 15.6% [42], a 2-week prevalence was esti-
mated at 9.9% [36]. Both estimates were for the gen-
eral Austrian population but measured with different
screening instruments.
Finally, data collection methods and sample self-
selection could further contribute to variations in the
findings and their generalizability. One study based
the prevalence rates of eating disorders on mail ques-
tionnaire responses from a sample selected based on
the census bureau data. As the response rate did
not reach 50%, the generalizability of findings is con-
sidered limited [40, 46]. In four other publications
the data presented were obtained via telephone in-
terviews [36–38, 42]. Relevant potential limitations to
consider are: language barriers and lower response
rate among migrant or lower socioeconomic groups
as reported for example by Kerkenaar et al. (2013)
[36].
Limitations of this review
The results of this review should be interpreted in the
light of certain limitations. Firstly, neurodevelopmen-
tal and neurocognitive disorders were not considered
in the analysis. This might limit comparisons with
the international literature where neurological and
mental diseases were analyzed together (e.g. Global
Burden of Disease Study [3], cost of disorders of
the brain in Austria [65], Wittchen et al. (2011) [4]).
Secondly, the paper focuses on studies investigating
mental diseases as primary diagnoses, and studies
describing mental diseases as comorbidities or con-
sequences of other health problems were excluded.
This leads to a systematic underestimation of the real
scope of mental health problems in Austria. Thirdly,
some relevant information may be missed, if an ar-
ticle did not explicitly refer to mental diseases in its
title, abstract or keywords (e.g. [66]). At the same
time, a comprehensive check of the references of
the included articles and a search of the relevant
websites should have ensured identification of the
most relevant direct evidence. Furthermore, studies
and reports containing information only on hospi-
tal admissions or discharge rates were excluded as
many experts argue that these data do not represent
accurate estimates due to coding bias and an under-
estimation of the real prevalence rates [67]. According
to the data from the national health insurance funds
in Austria, 0.8% of insured individuals with a primary
psychiatric diagnosis were hospitalized in 2007 which
constituted approximately 5% of all hospitalizations
[68].
Considerations for future research
Institutionalized populations, i. e. residents of long-
term care homes, prisons and hospitals, are often ex-
cluded from population-based epidemiological and
health services studies [7, 67]; however, the high oc-
currence of mental diseases among these groups indi-
cates that this is a major limitation in the current ev-
idence-base [52]. The review showed that more than
70% of Austrian nursing home residents and prison-
ers are potentially affected by mental and neurological
diseases. These results are in line with the interna-
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tional literature on the prevalence of mental health
problems in long-term care homes [69] and studies
on the incarcerated population in the USA and Eu-
rope [70].
The problem of general under-recognition and un-
dertreatment of mental illnesses was also highlighted
in a few studies [45, 48, 55]. A study on the older Vien-
nese population showed that depression in this group
is immensely undertreated. Over half of the study par-
ticipants diagnosed with major and minor depression
did not receive psychotherapeutic or pharmacologi-
cal treatment [45, 55]. These findings are in line with
both national and international evidence. For exam-
ple, Topitz et al. (2015) reported that only 46% of
the patients with depression were recognized by ward
physicians as being mentally ill and merely 21% of
patients suffering from depression had a documented
mental health disease diagnosis at discharge [71]. It
is unclear, however, whether concerns over stigmati-
zation of the patients or the insecurity of the doctors
regarding diagnoses caused this behavior [71]. Kessler
et al. (1994) reported that among respondents suffer-
ing from at least one mental health problem during
their lifetime, less than half received any professional
healthcare and only one fifth received care in the men-
tal healthcare sector [72]. Findings from other inter-
national studies arrived at similar conclusions. Lecru-
bier (2007) also found that only around half of the pa-
tients diagnosed with depression received any treat-
ment [73]. These results confirm a great unmet need
for interventions in patients with mental illnesses and
the possibility that a lack of diagnosis could be a con-
tributing factor to the lack of care received.
Internationally, specific epidemiological studies
were conducted to outline the scope of mental dis-
eases in a respective country or multiple European
countries. Such studies were conducted for example
in Germany (German Health Interview and Exami-
nation Survey, GSH) [6], USA (National Comorbidity
Survey, NCS) [72], UK (National Psychiatric Morbidity
Surveys of Great Britain, NPMS) [15], the Netherlands
(The Netherlands Mental Health Survey and Inci-
dence Study, NEMESIS) [5] and in Europe (European
Study of the Epidemiology of Mental Disorders, ES-
EMED) [7]. These studies provide the most reliable
estimates of mental diseases in general populations
and can serve as examples for future research. For
Austria, no similar study has been published so far,
neither in scope (the number of people) nor in detail
(the types of disorders).
Conclusion
Currently, due to the lack of robust epidemiological
evidence, decisions on mental healthcare services
planning are based on fragmented administrative
and historical data in Austria [74]. So far, no large
representative population-based study has been pub-
lished in Austria that would cover a comprehensive
range of psychiatric diagnoses together with relevant
socioeconomic and demographic information. Due
to the variety of methods and diagnostic tools used,
the non-representative samples, high drop-out rates
and other limitations, existing evidence on mental
diseases prevalence is not comparable, generalizable
or robust enough for planning purposes. The in-
formation consolidated in this paper highlights the
need for more detailed, representative studies using
validated methods and measures that would provide
a better understanding of the scope of different types
of mental diseases in the Austrian population.
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